| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HED.24865 |
| P698 | PubMed publication ID | 28691255 |
| P50 | author | Matthias Dettmer | Q50761586 |
| Martina A Broglie | Q90798142 | ||
| Laurence de Leval | Q38329862 | ||
| Massimo Bongiovanni | Q39864747 | ||
| P2093 | author name string | Martin Müller | |
| Andreas Arnold | |||
| Florian Lang | |||
| Roland Giger | |||
| Wolfram Jochum | |||
| Edouard Stauffer | |||
| Francesco Martucci | |||
| Philippe Pasche | |||
| Thomas F Pezier | |||
| Alex Soltermann | |||
| Sandro J Stoeckli | |||
| Gerhard F Huber | |||
| Vittoria Espeli | |||
| Stefan Spreitzer | |||
| Rafael Sauter | |||
| Andre Arnoux | |||
| Antoine Reinhard | |||
| Diana Foerbs | |||
| Mathieu Lutchmaya | |||
| P2860 | cites work | Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. | Q51766721 |
| A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. | Q51908580 | ||
| Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. | Q53794992 | ||
| Role of primary surgery in the treatment of advanced oropharyngeal cancer. | Q54284032 | ||
| Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. | Q54482654 | ||
| Detection and Typing of Multiple Genital Human Papillomaviruses by DNA Amplification with Consensus Primers | Q55378781 | ||
| High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma | Q56532872 | ||
| Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis | Q71838655 | ||
| T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study | Q79151663 | ||
| Changes in treatment of advanced oropharyngeal cancer, 1985-2001 | Q79487406 | ||
| Human papillomavirus and survival of patients with oropharyngeal cancer. | Q27851567 | ||
| Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial | Q27852908 | ||
| Case-control study of human papillomavirus and oropharyngeal cancer | Q28301695 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery | Q33520187 | ||
| Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence | Q33658257 | ||
| Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study | Q33809636 | ||
| Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial | Q34193953 | ||
| Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial | Q34749494 | ||
| Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes. | Q35875691 | ||
| Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach | Q35978949 | ||
| Cystic metastasis from head and neck squamous cell cancer: a distinct disease variant? | Q36396213 | ||
| Enhanced radiation sensitivity in HPV-positive head and neck cancer | Q37067398 | ||
| HPV-induced oropharyngeal cancer, immune response and response to therapy | Q37560351 | ||
| Unravelling the biology of human papillomavirus (HPV) related tumours to enhance their radiosensitivity. | Q37736757 | ||
| Transoral robotic surgery and human papillomavirus status: Oncologic results | Q37855737 | ||
| Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go? | Q37943790 | ||
| Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers | Q38209942 | ||
| Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology | Q39100076 | ||
| HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity | Q39163509 | ||
| Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation | Q39448913 | ||
| Oncologic outcomes of surgically treated early-stage oropharyngeal squamous cell carcinoma | Q40713738 | ||
| Brush cytology for the detection of high-risk HPV infection in oropharyngeal squamous cell carcinoma | Q41010595 | ||
| The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy | Q41240221 | ||
| Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. | Q41251899 | ||
| Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy | Q42215642 | ||
| Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma | Q43732858 | ||
| Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity | Q45346918 | ||
| Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. | Q46686980 | ||
| Histopathologic findings of HPV and p16 positive HNSCC | Q46706602 | ||
| Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function | Q48696890 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 2004-2015 | |
| P577 | publication date | 2017-07-10 | |
| P1433 | published in | Head & Neck | Q13703062 |
| P1476 | title | Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery | |
| P478 | volume | 39 |
| Q90798146 | Comparison of contemporary staging systems for oropharynx cancer in a surgically treated multi-institutional cohort |
| Q97093740 | Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation |
| Q59357202 | Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer |
| Q94556014 | Head and neck tumors angiogenesis imaging with 68Ga-NODAGA-RGD in comparison to 18F-FDG PET/CT: a pilot study |
| Q58761788 | Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma |
| Q58719251 | The impact of human papillomavirus (HPV) status on functional outcomes and quality of life (QOL) after surgical treatment of oropharyngeal carcinoma with free-flap reconstruction |
| Q97415120 | [Update for Diagnosis and Management of HPV-Driven Oropharyngeal Cancer] |
Search more.